Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 517,553 | 137,636 | 298,395 | 171,445 | 130,237 |
| Marketable Securities | N/A | N/A | N/A | 19,821 | 10,041 |
| Receivables | 65,476 | 53,514 | 10,439 | 6,619 | 5,987 |
| Inventories | 19,541 | 15,644 | 6,805 | 7,870 | 4,651 |
| TOTAL | $623,609 | $219,329 | $320,806 | $210,106 | $159,244 |
| Non-Current Assets | |||||
| PPE Net | 1,354 | 1,195 | 847 | 959 | 130 |
| Investments And Advances | 21,564 | 16,489 | 0 | 0 | 0 |
| Intangibles | 156,672 | 194,049 | 32,471 | 0 | 0 |
| Other Non-Current Assets | 48,212 | 39,052 | 21,506 | 26,723 | 32,980 |
| TOTAL | $227,802 | $250,785 | $54,824 | $27,682 | $33,110 |
| Total Assets | $851,411 | $470,114 | $375,630 | $237,788 | $192,354 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,593 | 14,795 | 3,975 | 2,768 | 4,256 |
| Accrued Expenses | 104,085 | 61,268 | 53,613 | 24,295 | 18,500 |
| TOTAL | $120,678 | $76,063 | $57,588 | $27,063 | $22,756 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,101 | 6,170 | 17,621 | 3,894 | 0 |
| TOTAL | $3,101 | $6,170 | $17,621 | $3,894 | $N/A |
| Total Liabilities | $123,779 | $82,233 | $75,209 | $30,957 | $22,756 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 121,450 | 117,863 | 105,654 | 102,745 | 103,825 |
| Common Shares | 121 | 107 | 105 | 103 | 104 |
| Retained earnings | 285,161 | 121,272 | 49,862 | -26,310 | -53,705 |
| Other shareholders' equity | 64 | 14 | 24 | -148 | 31 |
| TOTAL | $727,632 | $387,881 | $300,421 | $206,831 | $169,598 |
| Total Liabilities And Equity | $851,411 | $470,114 | $375,630 | $237,788 | $192,354 |